Certified by Founder Lodge
NYBC Ventures
- ND
INVESTOR
1 Disclosed Funding Rounds $90,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Taking an agnostic approach to financing vehicles and structures and employing a model of patient capital, we have developed streamlined scientific and investment due diligence teams to evalu
Company | Date | Round | Raised |
---|---|---|---|
Star Therapeutics | September, 05 ,2023 | Series C | $90,000,000 |
Aronora, Inc. | October, 16 ,2023 | Unknown | |
AvenCell | October, 22 ,2024 | Series B | $112,000,000 |